JVM Co

JVM Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of JVM Co (054950.KQ) as of Nov 4, 2026 is 107.15 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 89.87 % — a change of 19.22% (higher).

Cash Conversion

107.15 %

YoY

19.22%

Last updated:

Cash Conversion Rate (OCF/Net Income) of JVM Co is 2025 107.15 % . Cash Conversion Rate (OCF/Net Income) of JVM Co was 2024 89.87 % . It decreases by 19.22% higher compared to the previous year.

The JVM Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
243.98 KRW
Jan 1, 2019
320.14 KRW
Jan 1, 2020
189.56 KRW
Jan 1, 2021
291.45 KRW
Jan 1, 2022
93.69 KRW
Jan 1, 2023
114.03 KRW
Jan 1, 2024
89.87 KRW
Jan 1, 2025
107.15 KRW
The JVM Co Cash Conversion history
YEARCash ConversionYoY
107.15 %+19.22%
89.87 %-21.18%
114.03 %+21.70%
93.69 %-67.85%
291.45 %+53.75%
189.56 %-40.79%
320.14 %+31.22%
243.98 %+55.35%
157.05 %+16.92%
134.32 %-47.22%
254.47 %+18.73%
214.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Cash Conversion Rate (OCF/Net Income) of JVM Co is 107.15 % in 2025.

Cash Conversion Rate (OCF/Net Income) of JVM Co changed from 89.87 % to 107.15 %, representing a 19.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) JVM Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s JVM Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — JVM Co

All Key Metrics — JVM Co